Jump to navigation
Language:
English
Čeština
Deutsch
Español
Français
Hrvatski
日本語
한국어
Bahasa Malaysia
Polski
Português
Română
Русский
தமிழ்
ภาษาไทย
简体中文
繁體中文
More languages available
Show fewer languages
Top menu
Media
Contact us
Community
My Account
Cochrane
Trusted evidence.
Informed decisions.
Better health.
Enter terms
Retain current filters
|
Reset
1
search result
Current search:
Has podcast
Updated
Reset
Primary tabs
Cochrane Evidence
(active tab)
Resources
Handbooks & Manuals
Training & Workshops
News
All Cochrane sites
Enter terms
Sort by...
Best match
Alphabetically (A-Z)
Alphabetically (Z-A)
Date published (desc)
Hide descriptions
Subscribe to this search
Updated
Cochrane Evidence
Published
21 Jun 2017
Anti-vascular endothelial growth factor (anti-VEGF) drugs for diabetic macular oedema
What is the aim of this review? The aim of this Cochrane Review was to find out which is the best type of anti-VEGF drug for diabetic macular oedema (DMO). Cochrane researchers collected and analysed all relevant studies to answer this question and found 24 studies. Key messages Anti-VEGF drugs given by injection into the eye improve vision in people ...
Show more
Show less
Loading more results...
There are no more results.
Our evidence
About us
Join Cochrane
Get involved
News and events
Cochrane Library
►